Blavatnik Family Foundation reposted this
We are pleased to announce the that Harvard Business School recenrtly named its 2024-25 Blavatnik Fellows and the program's eleventh cohort! The Blavatnik Fellowship offers Harvard Business School alumni and Harvard-affiliated postdoctoral researchers the opportunity to advance new ventures around promising life science technologies and develop their leadership talents during a 12-month fellowship year. Congratulations to this year's fellows: - Narek Dshkhunyan (MBA 2024) - the CEO and co-founder of Sanso, a biomanufacturing startup aiming to make biologics more accessible to patients worldwide - Aaron Edwards (MS/MBA 2024) - co-founder and CEO of KiraGen Bio, a biotech company that utilizes machine learning-driven multiplex gene editing to engineer CAR-T cells that can resist the immunosuppressive effects of solid tumor microenvironments - Stephen Linderman (MD, PhD 2019) - the CEO and co-founder of Absco Therapeutics (AbscoTx), an immune oncology company specializing in image-guided, intratumoral drug delivery - Somani Patnaik (MBA 2023) - the co-founder and CEO of TurnipCare, an AI-based referral management and care coordination platform - Andrew Thomson (MBA 2024) - co-founder and CEO of Modulate Bio, a biotechnology company developing next-generation therapies to treat neurological disorders, including tremors, epilepsy and anxiety "It is gratifying to be a part of the program to enable the next generation of entrepreneurs who are developing groundbreaking technology and biomedical innovation,” said Peter Barrett, Harvard Business School Executive Fellow, PhD. Read more in the Harvard Gazette's story here: https://lnkd.in/eSDAwpXJ